---
title: How I Treat Sickle Cell Disease with Gene Therapy
date: '2024-10-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39356871/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241003195203&v=2.18.0.post9+e462414
source: Blood
description: In 2023, two different gene therapies were approved for individuals with
  severe sickle cell disease (SCD). The small number of patients treated on the pivotal
  clinical trials that led to these approvals have experienced dramatic short-term
  reductions in the occurrence of painful vaso-occlusive crises, but the long-term
  safety and efficacy of these genetic therapies are yet to be ascertained. Several
  challenges and treatment-related concerns have emerged in regard to administering
  these ...
disable_comments: true
---
In 2023, two different gene therapies were approved for individuals with severe sickle cell disease (SCD). The small number of patients treated on the pivotal clinical trials that led to these approvals have experienced dramatic short-term reductions in the occurrence of painful vaso-occlusive crises, but the long-term safety and efficacy of these genetic therapies are yet to be ascertained. Several challenges and treatment-related concerns have emerged in regard to administering these ...